
CCP Launches Chikungunya Virus Testing in Foshan, Sparking Fears of Lockdown
As of July 31, the total number of officially confirmed cases of chikungunya fever reported in Foshan, Guangdong Province, was more than 6,000, according to Chinese state media. The first case was reported on July 8. On Aug. 1, Foshan authorities reported 333 newly confirmed cases in one day.
Chikungunya fever is a viral disease mainly transmitted to humans by mosquitoes. Its symptoms are similar to those of dengue fever. Patients usually experience fever, severe joint pain, muscle pain, headache, fatigue, and rash.
There is no specific antiviral treatment for chikungunya. Deaths from the disease are rare but do occur, especially among vulnerable populations such as those with underlying health conditions.
Confirmed cases have been reported in more than 10 cities in Guangdong Province, according to the Guangdong Provincial Center for Disease Control and Prevention.
On July 31, the Department of Medical Emergency Response of the Chinese regime's National Health Commission issued an urgent nationwide notice for diagnosis and treatment plans for the chikungunya fever outbreak.
In the notice, the central authorities said there is currently no chikungunya virus vaccine available in China. They said that 'quarantine measures must be taken' for suspected and confirmed cases.
Meanwhile, local authorities in Foshan, which is hardest-hit by chikungunya fever, initiated a Level III public health emergency response on July 29.
In China, there are four official response levels: Level I (extremely serious), Level II (serious), Level III (major), and Level IV (general).
Residents in Foshan told local media that they had received an official notice that chikungunya virus PCR screening would be conducted as part of a three-day mass testing effort from July 29 to July 31.
On July 30, the Shabian Village Residents Committee of Lecong Town in Foshan's Shunde district told local media that the whole town had received notice of mass PCR screening for the chikungunya virus for July 29 to July 31.
Videos circulating on social media showed Guangdong residents lining up for PCR testing and epidemic prevention personnel fumigating Foshan to kill mosquitoes.
Spreading Outside Guangdong
The chikungunya outbreak had spread to Macau and Beijing a few days earlier, according to local health authorities.
On July 29, health authorities in Fuzhou, Fujian Province, in southeast China posted an alert about chikungunya fever and dengue fever on their WeChat public account, requiring that 'people returning from Foshan must monitor their health for 14 days at home.'
The U.S. Centers for Disease Control and Prevention issued a Level 2 travel alert on Aug. 1, advising people planning to visit China to 'practice enhanced precautions' due to a significant chikungunya virus outbreak in Foshan City.
Meanwhile, the World Health Organization (WHO) has raised concerns of another chikungunya virus epidemic. The WHO said it has noticed the same early warning signs as were seen before a major outbreak two decades ago that infected more than 5 million people. That epidemic started in Kenya and spread to countries primarily in the Indian Ocean region, South Asia, and Southeast Asia—and later, to parts of tropical and subtropical Europe and the Americas.
'We are calling for urgent action to prevent history from repeating itself,' Dr. Diana Rojas Alvarez, medical officer at the WHO, told reporters on July 22. 'There is no particular treatment for chikungunya, so people need to avoid mosquito bites.'
Chikungunya fever can spread rapidly.
'Based on the life habits of the Aedes aegypti mosquitoes, its vector, and the virus's activity in both humans and mosquitoes, it is estimated that in a community with a high Aedes aegypti population, a single infected person could transmit the virus to over 2,400 people through mosquito bites within 30 days,' Dr. Cheng Yuan-yu, attending physician at Shang-wen Clinic in Kaohsiung, Taiwan, who specializes in infectious diseases, told The Epoch Times on Aug. 2.
If the epidemic continues to worsen, there is a high chance that countries will issue travel warnings, according to Cheng.
'[However,] travel bans are unlikely, as this is a disease with a low mortality rate and a low severe case rate,' he said.
'Prevention measures primarily involve monitoring and tracking incoming travelers for symptoms, particularly body temperature.'
Sean Lin, assistant professor in the Biomedical Science Department at Feitian College and former U.S. army microbiologist, shared a similar assessment, saying he does not think that travel bans will be necessary.
He said 'there is no need' for the Chinese regime to impose quarantines 'because the virus isn't transmitted from person to person but rather through mosquitoes.'
'Local authorities can generally control the epidemic by implementing mosquito control campaigns and maintaining good hygiene,' Lin told The Epoch Times on Aug. 2.
This outbreak in China is likely 'related to changes in the local mosquito population and their adaptability to the virus,' Lin said, noting that 'the Chinese government hasn't been able to produce a timely research report on this.'
He said some people who are infected by chikungunya virus are at risk of long-term joint pain.
As for the mass free testing being promised by the authorities, Lin said it's not really free. 'If you test positive and are sent to the hospital for quarantine, it will incur various costs,' he said.
'So generally speaking, ordinary people are still indirectly footing the bill, and pharmaceutical companies are making money out of it.'
He added that spending public funds on PCR testing for Chikungunya is unnecessary because 'currently, there are no medications that can effectively treat the disease, so even if you tested positive, then what?'
CCP's Mandatory Measures Sparking Fear
Many Chinese citizens have been sharing their experiences of the Chinese Communist Party (CCP) chikungunya control measures on social media. Some fear that the draconian lockdown measures that the CCP employed during the three-year COVID-19 pandemic may come back.
A Foshan resident infected with chikungunya virus posted a video on social media claiming to have not been allowed to leave the Longjiang Hospital in Shunde district after having a blood test.
Another resident said in a video post that he has been in forced quarantine in a hospital for four days, with medical staff monitoring him for 24 hours a day. The video showed security guards at the quarantine site.
Others commented on social media about Foshan's mass testing and 'long lines,' reminiscent of the long testing lines during the COVID-19 pandemic.
'Do we need to be quarantined?' another post reads. 'Will they lock down the city?'
'No way!' another comment reads. 'Why do we have to wear masks every day again?'
On July 29, CCP officials held a national video and telephone conference in Beijing on chikungunya fever prevention and control. Its control measures include a mosquito eradication campaign. A video on social media showed the Foshan government deploying a large number of armed police officers to 'exterminate mosquitoes.'
A Chinese citizen commented on the video: 'The armed police has even been deployed. This feels a bit serious.'
Another comment reads, 'Are they planning to lock down Foshan and Shunde?'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
44 minutes ago
- Newsweek
Map Shows US States Where COVID Cases Are Rising
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. COVID-19 cases are rising in 31 states and "likely growing" in 14 others, according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC). The government agency, which coordinated the national response to the pandemic, said that 45 states were seeing high chances of increased COVID cases, five years after the pandemic began. Why It Matters Since the start of the pandemic, heath authorities have kept an eye on the number of cases across the world. While the development of a vaccine means that increased cases will no longer be met with the same lockdown policies, COVID cases are still a cause for concern, especially for the unvaccinated and immunocompromised. What To Know The number of states in which COVID cases appear to be growing has increased from 27 to 31 since August 5. Most significantly, the data shows that California switched from "likely growing" to "growing," meaning that the most populous state in the union is now measuring an increasing number of COVID cases. Other large population hubs, like Texas, New York and Florida, have stayed in the "growing" category. A majority of the U.S. population lives in a "growing" state. The only states to report no growth in COVID cases were Alaska, Maine, New Hampshire and North Dakota, along with Washington, D.C. A spokesperson for the CDC told Newsweek that "COVID-19 activity is increasing in many Mid-Atlantic, Southeast, Southern and West Coast states. The most recent genomic surveillance estimates indicated that the most common variants in the U.S. were NB. 1.8.1 and LP. 8.1 in late June. "Due to low numbers of sequences reported to CDC, precision in the most recent reporting period is low." What People Are Saying Dr. Steven Goldberg, a physician and chief medical officer at HealthTrackRx, told Newsweek: "The current rise in COVID-19 cases is likely multifactorial. Increased summer travel, indoor gatherings due to high temperatures, waning vaccine immunity and the emergence of immune-evasive Omicron subvariants like KP.3 and LB.1 all play a role. "Wastewater surveillance, along with anecdotal reports of increased COVID-19-related ER and urgent care visits, corroborate this increase." The Centers for Disease Control and Prevention, in a statement: "As of August 5, 2025, we estimate that COVID-19 infections are growing or likely growing in 45 states, declining or likely declining in 0 states, and not changing in 5 states." What Happens Next The CDC will continue to monitor any spread of COVID across the U.S.


Politico
an hour ago
- Politico
The MAHA wave
Driving the Day IN THE STATES — Health Secretary Robert F. Kennedy Jr.'s Make America Healthy Again campaign to combat chronic disease is reshaping state legislatures, with hundreds of bills introduced this year echoing his agenda in both red and blue states, POLITICO's Amanda Chu reports. A POLITICO analysis of state legislatures found more than 130 pieces of legislation aimed at limiting access to ultraprocessed foods and improving nutrition, over 60 measures restricting the use of pesticides and other chemicals and more than 130 measures expanding vaccine exemptions or prohibiting mandates were introduced this year. Lawmakers also introduced dozens of bills to promote the use of psychedelics, authorize sales of raw milk and the antiparasitic drug ivermectin and ban the fluoridation of drinking water. The advances seen in state capitols, often considered laboratories for federal rulemaking, offer a glimpse into how a Kennedy-run Department of Health and Human Services might turn MAHA priorities into regulation. The White House is set to release a final MAHA report, which will include recommendations to fight chronic disease. Details: POLITICO tracked nearly 900 measures on MAHA-aligned subjects that were introduced in 50 states this year — a 45 percent increase from the previous year and measures introduced in 2023 among the four states that meet every two years. Measures ranged from banning the use of food dyes to limiting children's access to social media over mental health concerns to restricting the use of mRNA, the technology behind the Pfizer and Moderna Covid-19 vaccines. The surge in state activity underscores the growing political clout of the MAHA base, which cuts across party lines, and offers MAHA supporters a chance to secure policy wins outside a White House navigating competing interests. Following intense pressure from agricultural lobbyists, the Trump administration assured farm groups earlier this summer that the final MAHA report would include no new policy around pesticide use despite linking the chemical to cancer in a May draft report. Bipartisan appeal? Blue states New York and New Jersey led the country in the number of MAHA-aligned measures introduced this year, followed by Republican-led Texas. While some topics, like ending vaccine mandates, were predominantly backed by one party, a few themes had bipartisan traction: Roughly a third of measures to improve nutrition and restrict food additives were sponsored by at least one member of each party this year. 'We see so much state activity. … It's bipartisan. They're tapping into something that most Americans know intuitively. MAHA will persist when Kennedy is gone in the future,' said Joel White, a Republican health care strategist and founder of Horizon Government Affairs, a Washington lobbying firm. WELCOME TO THURSDAY PULSE. Adults in the U.S. are drinking less and worrying more about alcohol's health effects, according to new numbers from Gallup. Send your tips, scoops and feedback to khooper@ and sgardner@ and follow along @kelhoops and @sophie_gardnerj. At the White House PRASAD BACKSTORY — White House chief of staff Susie Wiles advocated to bring back the FDA's top vaccine regulator, Dr. Vinay Prasad, after he was pushed out following social media attacks from MAGA influencer Laura Loomer, POLITICO's David Lim, Dasha Burns and Tim Röhn report. Wiles' decision to advocate on Prasad's behalf, as described to POLITICO by two senior administration officials granted anonymity to discuss sensitive details, came after pleas from both Prasad's boss, FDA Commissioner Marty Makary, and Health Secretary Robert F. Kennedy Jr. They insisted that Prasad is part of Kennedy's broader Make America Healthy Again movement to combat chronic diseases and integral to the Trump coalition. Loomer did not respond immediately to a request for comment. The FDA referred questions to the White House. 'Secretary Kennedy and the entire HHS team are doing a terrific job as they deliver on President Trump's mandate to Make America Healthy Again,' White House spokesperson Kush Desai said. 'Scores of prominent restaurant chains and food brands dropping artificial ingredients from our food supply and historic reforms at the FDA to fast-track lifesaving drugs and treatments prove that the entire HHS team is delivering for the American people.' Background: President Donald Trump forced Prasad out of his FDA job less than two weeks earlier after the Cambridge, Massachusetts, pharmaceutical manufacturer Sarepta Therapeutics, joined by GOP allies and Loomer, sought his ouster. He abruptly returned last week. Read the full story here. DRUG STOCKPILE EO — President Donald Trump issued an executive order Wednesday aimed at bolstering the domestic supply of drugs by ordering his health department to fill a drug-ingredient stockpile he established during his first term, POLITICO's Lauren Gardner reports. The directive builds on the Strategic Active Pharmaceutical Ingredients Reserve that Trump established in 2020 during the Covid-19 pandemic when shortages of medical supplies and devices hampered the pandemic response. The U.S. relies largely on China, India and the European Union for APIs, particularly those that go into commonly used generic medicines like antibiotics and chemotherapies that are manufactured on low margins. Details: The order directs the Office of the Assistant Secretary for Preparedness and Response — the HHS agency that focuses on emergency readiness — to develop a list of 'approximately' 26 drugs considered critical to domestic health and security interests. It calls for an accounting of available funding that can be used to open the stockpile and to secure and maintain a six-month supply of active pharmaceutical ingredients needed to make the critical drugs. In Congress PRO MEDICAID CUTS — An influential group of Republicans has invited a key proponent of slashing Medicaid to brief congressional aides as the GOP mulls a potential second reconciliation bill, POLITICO's Benjamin Guggenheim and Meredith Lee Hill report. Brian Blase, president of the conservative think tank Paragon Health Institute, is set to address staff Thursday at a briefing on health care reform hosted by the Republican Study Committee, according to an invitation obtained by POLITICO. Blase was allied with conservative hard-liners earlier this year in pushing for significant cuts to Medicaid in the first GOP package. He was the initial author of a letter arguing for 'structural' changes to the program that Rep. Chip Roy (R-Texas) and 19 other hard-right members later sent to their House Republican colleagues. Details: An RSC spokesperson declined to comment on Thursday's briefing. But a person granted anonymity to discuss plans in advance said the meeting is set to cover enhanced tax credits for Affordable Care Act health insurance premiums, which are due to expire at the end of the year, as well as rules governing the percentage of Medicaid expenditures covered by the federal government and reimbursed to states. Not unprecedented: The RSC, composed of 189 House conservatives, has been a key force pushing for a follow-on to President Donald Trump's 'big, beautiful bill' that was signed into law last month. The group has invited several conservative experts to address staffers in recent weeks, though it has yet to endorse any specific health care policies for any forthcoming package. Those staff-level meetings continue as House GOP leaders try to plot a way forward amid skepticism over whether another sprawling domestic policy bill is even possible, given the difficulties Republicans had coming to an agreement on the first bill. Looking forward: It's still unclear what health topics a possible second package would address. Some House GOP factions are discussing further slashing Medicaid as well as possibly targeting Medicare funding. AROUND THE AGENCIES MAHA REPORT TIMELINE — The White House told several agricultural industry representatives to expect the latest Make America Healthy Again report to be publicly released in September, according to two people familiar with the conversation, POLITICO's Grace Yarrow reports. Some farm groups were recently invited to the White House and given 20 to 30 minutes to view a hard copy of a draft strategy report, said the two people, who were granted anonymity to share private details. The draft report that groups have seen is roughly 15 pages and has only 'light' mentions of pesticides, one of the two people said. But given that officials plan to wait for weeks before publishing the report, anything could change. Farm groups are crossing their fingers that the MAHA Commission won't scale up plans last minute to crack down on pesticides. 'If the ag community felt like they'd had some success in mitigating some of the worst language, or even taking some of that stuff out, an extra month may not feel like an opportunity,' said one of the people. 'It actually might feel like a bigger risk, because if they're already comfortable with where it sits now, what does an extra month mean?' 'On the other side, the MAHA folks are going to be pushing for more aggressive policy solutions across the board,' the person added. 'Maybe it would have been better for it to just pop out as it is.' Buckle up: Behind the scenes, the White House is taking extra time to review the policy recommendations to 'make sure it's not fucked up like last time,' as one person familiar with the process told our Dasha Burns, referencing the first error-riddled report from the MAHA Commission earlier this year. An HHS official told our Playbook colleagues that 'the team at the White House and HHS is ensuring that whatever is in the report is the best possible product for the American people. If they need more time, they need more time.' WHAT WE'RE READING The New York Times' Roni Caryn Rabin and Irena Hwang report on the Trump administration halting research related to racial and socio-economic disparities.


Boston Globe
3 hours ago
- Boston Globe
Fall vaccines: Here's what you need to know about COVID, flu and RSV shots
Amid uncertainty at the federal level, the Globe spoke with experts to guide readers on which vaccines are available, what doctors are recommending, and where to find reliable sources of information. Related : Advertisement COVID-19 Though the CDC's Advisory Committee on Immunization Practices has yet to officially weigh in on the COVID-19 vaccine, Kennedy While the Advertisement The Food and Drug Administration is also weighing whether to revoke its The American Academy of Pediatrics continues to recommend that all children starting at six months receive the COVID vaccine, even if they're healthy, Anders Pring said. According to Anders Pring recommends every child starting at age six months receive the 'primary series,' the two initial doses. For older children, Anders Pring recommends getting an annual booster, just like the flu shot. Naima Joseph, a maternal fetal medicine specialist at Boston Medical Center, recommends pregnant patients also receive the COVID-19 vaccine. Insurance companies are mandated to cover ACIP's recommendations. But since the panel's final recommendation has not been released, insurance companies have promised to accept the guidance from medical societies, Joseph said. 'We are hopeful that given AHIP has stated an intent to continue coverage of vaccines, it won't be a problem,' Joseph said. 'We will continue to partner with clinicians, pharmacists, community health workers to ensure equitable distribution of vaccines.' Advertisement Influenza The CDC still recommends the flu vaccine for everyone six months and older. But, in late June, Kennedy approved the CDC advisory committee's recommendation to Thimerosal, a mercury-based chemical compound, is used like a preservative in multi-dose vials. The ingredient has long been pushed by the anti-vaccine movement as being connected to autism, though that The move should not affect the supply of flu vaccines, doctors said, as thimerosal is used in less than 5 percent of U.S. flu vaccinations. Manufacturers Boston Medical Center is 'proactive in looking at supply chains throughout the year to ensure that we have sufficient stock,' said Cassandra Pierre, an infectious disease physician there. RSV Respiratory syncytial virus, which causes infections of the lungs and respiratory tract, primarily infects young children under 2 years old. It also impacts the elderly, especially those with weakened immune systems and chronic lung conditions. RSV infections are As of Aug. 4, the CDC In June, the federal panel approved a recommendation for Advertisement For pregnant women, the CDC recommends a single dose of the maternal RSV vaccine — in particular, Pfizer's Abrysvo — during weeks 32 through 36 of pregnancy. The RSV vaccine given to mothers allows antibodies to be passed to the baby before birth. Doctors agree that RSV vaccines are recommended for these populations. Pneumonia Pneumonia vaccines are available throughout the year, Pierre said. The It also recommends it for individuals who have underlying health conditions that put them at high risk for severe disease. That includes people with HIV, asthma or significant pulmonary disease, or diabetes, according to Pierre. Where can I find reliable information about vaccines? Pierre said guidance from professional organizations, like the American Academy of Pediatrics and the American Medical Association, are resources to look to. She added state and local boards for public health are 'wonderful unsung gems.' The While such resources exist, doctors ultimately urged patients to consult with their own clinicians. 'From a public health perspective, we as pediatricians love to talk with our patients and work with them,' Anders Pring said. Advertisement Jessica Ma can be reached at